G
Gian Luca Salvagno
Researcher at University of Verona
Publications - 428
Citations - 12680
Gian Luca Salvagno is an academic researcher from University of Verona. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 49, co-authored 397 publications receiving 10707 citations. Previous affiliations of Gian Luca Salvagno include University of Milan & Cincinnati Children's Hospital Medical Center.
Papers
More filters
Journal ArticleDOI
How to assess the quality of your analytical method
Elizabeta Topić,Nora Nikolac,Mauro Panteghini,Elvar Theodorsson,Gian Luca Salvagno,Marijana Miler,Ana-Maria Simundic,Ilenia Infusino,Gunnar Nordin,Sten A. Westgard +9 more
TL;DR: Insight is provided into how to validate the laboratory assays and assess the quality of methods and the leading topics to be discussed include who, what and when to do in validation/verification of methods.
Journal ArticleDOI
Lipoprotein[a] and the lipid profile in patients with systemic sclerosis.
Giuseppe Lippi,Paola Caramaschi,Martina Montagnana,Gian Luca Salvagno,Alessandro Volpe,Gian Cesare Guidi +5 more
TL;DR: It is hypothesized that Lp[a] measurement might be useful in SSc to identify and eventually treat subsets of patients more predisposed to develop thrombotic complications, and further studies will strengthen these preliminary findings.
Journal ArticleDOI
Prevalence of thyroid autoimmunity and subclinical hypothyroidism in persons with chronic kidney disease not requiring chronic dialysis
Giovanni Targher,Michel Chonchol,Giacomo Zoppini,Gian Luca Salvagno,Isabella Pichiri,Massimo Franchini,Giuseppe Lippi +6 more
TL;DR: Thyroid autoimmunity and subclinical primary hypothyroidism are highly prevalent in persons with CKD not requiring chronic dialysis, and decreasing eGFR values appeared to be more strongly related with the increase in TSH rather than antithyroid antibodies.
Journal ArticleDOI
Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes
Alessandro Mantovani,Teresa Turino,Maria Giovanna Lando,Kamela Gjini,Christopher D. Byrne,Chiara Zusi,Federico Ravaioli,Antonio Colecchia,Claudio Maffeis,Gian Luca Salvagno,Giuseppe Lippi,Enzo Bonora,Giovanni Targher +12 more
TL;DR: It is suggested that NAFLD and significant LF are very commonly seen in T2DM outpatients with no known liver disease attending a secondary-care diabetes service, and that increased LF is associated with a greater proportion of chronic vascular complications, especially CKD.
Journal ArticleDOI
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes.
Alessandro Mantovani,Elena Sani,Angelo Fassio,Antonio Colecchia,Ombretta Viapiana,Davide Gatti,Luca Idolazzi,Maurizio Rossini,Gian Luca Salvagno,Giuseppe Lippi,Giacomo Zoppini,Christopher D. Byrne,Enzo Bonora,Giovanni Targher +13 more
TL;DR: In post-menopausal women with T2DM, the presence of NAFLD and clinically significant fibrosis was strongly associated with a low bone turnover, which may reflect the presenceof qualitative bone abnormalities.